Our Newsletters

Filter By: 
 

2009

Date Title
April 2, 2009

FDA Rebuked by Seventh Circuit Over Interpretation of Labeling Claims

Type: On the Subject

March 16, 2009

President Obama Announces FDA Commissioner and Deputy Commissioner Appointments

Type: On the Subject

February 9, 2009

New FDA Guidance on Adverse Event Reporting to the IRB

Type: On the Subject

January 21, 2009

Early Government Enforcement and Oversight Activity Promises a Challenging 2009

Type: On the Subject

January 9, 2009

AdvaMed Adopts Revised Code of Ethics on Interactions with Health Care Professionals

Type: On the Subject

 

2008

Date Title
October 1, 2008

FDA Challenges Implied Outcomes Claims for Several ADHD Products: An Analysis

Type: On the Subject

August 21, 2008

FDA Confirms Its View on Generic Drug Label Carve-Outs

Type: On the Subject

July 15, 2008

PhRMA Revises Code on Interactions with Healthcare Professionals

Type: White Papers

May 29, 2008

Merck Settles Vioxx® Litigation with State Attorneys General: an Analysis

Type: White Papers

May 19, 2008

CMS Proposed Rule Revisits PBM Pricing Arrangements, Proposes Other Medicare Advantage and Part D Program Changes

Type: On the Subject

April 29, 2008

FDA Issues Draft Guidance on Certification Requirements Under New Clinical Trial Registration and Posting Provisions

Type: On the Subject

April 14, 2008

Third Circuit Decides Long-Awaited Antidepressant Drug Labeling Preemption Cases

Type: On the Subject

February 19, 2008

FDA Releases Draft Guidance on Dissemination of Reprints of Peer Reviewed Journal Article

Type: On the Subject

McDermott Will & Emery

McDermott Will and Emery